Iran’s radiopharmaceutical supply continues without disruption despite rising regional conflict, according to nuclear officials. Leaders say production systems remain stable and fully operational. Mohammad Eslami, head of the Atomic Energy Organization of Iran, confirmed ongoing production and distribution of medical isotopes. He said health services continue normally across the country.
Moreover, Eslami explained that scientists rely on domestic expertise to maintain nuclear technology operations. Therefore, the country does not depend on foreign support for key medical materials. Radiopharmaceuticals play a critical role in diagnosing and treating diseases. Hospitals use them widely in cancer detection and advanced imaging procedures.
Consequently, stable production remains essential for patient care nationwide. Officials say uninterrupted supply protects thousands of ongoing treatments. Furthermore, Eslami stated that planners secured raw materials for continued manufacturing. Authorities also created backup supply routes to prevent shortages.
As a result, medical centers continue receiving shipments from national production facilities. The Iranian radiopharmaceutical supply, therefore, remains stable across the healthcare system. Meanwhile, the announcement came during a period of escalating regional tensions. Military conflict has created serious security concerns throughout the region.
Iranian officials say attacks targeted several national facilities and infrastructure. However, authorities claim critical nuclear operations continue without interruption. Government leaders argue that the nuclear program relies on decades of local scientific development. Therefore, engineers and researchers maintain production even during external pressure.
At the same time, political tensions intensified following the death of Ali Khamenei. He led the country for decades before his assassination in Tehran. Following that event, the Assembly of Experts elected Mojtaba Khamenei as the next Supreme Leader. The decision created a new leadership phase for the country.
In addition, Iran’s armed forces launched retaliatory military operations in response to regional attacks. Officials described those operations as defensive measures. However, health authorities stress that medical services remain a priority. They say patient care must continue regardless of political developments.
Industry analysts note that nuclear medicine represents a strategic healthcare sector for Iran. Domestic production reduces reliance on imported medical isotopes. Therefore, experts believe the current stability demonstrates resilience within Iran’s scientific infrastructure. Research centers and laboratories continue operating despite external pressures.
Looking ahead, authorities plan to expand nuclear medicine capabilities further. Officials say new projects will strengthen production capacity and medical research. In conclusion, leaders emphasize that the Iranian radiopharmaceutical supply remains secure. Healthcare providers continue receiving materials needed for diagnosis and treatment nationwide.